 | • レポートコード：MRC2210A0072 • 出版社/出版日：Transparency Market Research / 2022年7月 • レポート形態：英文、PDF、211ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査レポートでは、世界のPOC（ポイントオブケア）血液凝固分析機器市場規模について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要洞察、製品別（機器/アナライザー、消耗品・付属品)分析、メソッド別（PT/INR、粘弾性凝固測定、その他）分析、エンドユーザー別（病院、診断ラボラトリー、診療所）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東/アフリカ）分析、競争状況など、以下の項目を掲載しております。本書では、F.Hoffmann-La Roche AG、Abbott Laboratories、Siemens Healthineers、Medtronic plc、Haemonetics Corporation、HemoSonics,LLC、Micropoint Bioscience,Inc.、Werfen、Sienco,Inc.、Koninklijke Philips N.V.などの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要洞察 ・世界のPOC（ポイントオブケア）血液凝固分析機器市場規模：製品別 - POC（ポイントオブケア）血液凝固分析用機器/アナライザーの市場規模 - POC（ポイントオブケア）血液凝固分析用消耗品・付属品の市場規模 ・世界のPOC（ポイントオブケア）血液凝固分析機器市場規模：メソッド別 - PT/INR測定式POC（ポイントオブケア）血液凝固分析機器の市場規模 - 粘弾性凝固測定式POC（ポイントオブケア）血液凝固分析機器の市場規模 - その他メソッドの市場規模 ・世界のPOC（ポイントオブケア）血液凝固分析機器市場規模：エンドユーザー別 - 病院における市場規模 - 診断ラボラトリーにおける市場規模 - 診療所における市場規模 ・世界のPOC（ポイントオブケア）血液凝固分析機器市場規模：地域別 - 北米のPOC（ポイントオブケア）血液凝固分析機器 - ヨーロッパのPOC（ポイントオブケア）血液凝固分析機器 - アジア太平洋のPOC（ポイントオブケア）血液凝固分析機器 - 中南米のPOC（ポイントオブケア）血液凝固分析機器 - 中東/アフリカのPOC（ポイントオブケア）血液凝固分析機器 ・競争状況 |
Point-of-Care (POC) Coagulation Testing Devices Market – Scope of Report
TMR’s report on the global point-of-care coagulation testing devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global point-of-care coagulation testing devices market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global point-of-care coagulation testing devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the point-of-care coagulation testing devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global point-of-care coagulation testing devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global point-of-care coagulation testing devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global point-of-care coagulation testing devices market.
The report delves into the competitive landscape of the global point-of-care coagulation testing devices market. Key players operating in the global point-of-care coagulation testing devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global point-of-care coagulation testing devices market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market point-of-care coagulation testing devices.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Point-of-Care Coagulation Testing Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Instruments / Analyzers
6.3.2. Consumables & Accessories
6.4. Market Attractiveness Analysis, by Product
7. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Method
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Method, 2017–2031
7.3.1. PT/INR
7.3.2. Viscoelastic Coagulation Monitoring
7.3.3. Others (ACT, aPTT, etc.)
7.4. Market Attractiveness Analysis, by Method
8. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Clinics
8.4. Market Attractiveness Analysis, by End-user
9. Global Point-of-Care Coagulation Testing Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Instruments / Analyzers
10.2.2. Consumables & Accessories
10.3. Market Value Forecast, by Method, 2017–2031
10.3.1. PT/INR
10.3.2. Viscoelastic Coagulation Monitoring
10.3.3. Others (ACT, aPTT, etc.)
11. Europe Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Instruments / Analyzers
11.2.2. Consumables & Accessories
11.3. Market Value Forecast, by Method, 2017–2031
11.3.1. PT/INR
11.3.2. Viscoelastic Coagulation Monitoring
11.3.3. Others (ACT, aPTT, etc.)
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Clinics
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Method
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Instruments / Analyzers
12.2.2. Consumables & Accessories
12.3. Market Value Forecast, by Method, 2017–2031
12.3.1. PT/INR
12.3.2. Viscoelastic Coagulation Monitoring
12.3.3. Others (ACT, aPTT, etc.)
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Clinics
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Method
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Instruments / Analyzers
13.2.2. Consumables & Accessories
13.3. Market Value Forecast, by Method, 2017–2031
13.3.1. PT/INR
13.3.2. Viscoelastic Coagulation Monitoring
13.3.3. Others (ACT, aPTT, etc.)
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Clinics
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Method
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Point-of-Care Coagulation Testing Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Instruments / Analyzers
14.2.2. Consumables & Accessories
14.3. Market Value Forecast, by Method, 2017–2031
14.3.1. PT/INR
14.3.2. Viscoelastic Coagulation Monitoring
14.3.3. Others (ACT, aPTT, etc.)
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Clinics
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Method
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Abbott Laboratories
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Siemens Healthineers
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Medtronic plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Haemonetics Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. HemoSonics, LLC
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Micropoint Bioscience, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Werfen
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Sienco, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Koninklijke Philips N.V.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
Table 01: Global Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product, 2022-2031
Table 02: Global Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
Table 03: Global Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
Table 04: Global Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Region, 2022-2031
Table 05: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product, 2022-2031
Table 06: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
Table 07: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
Table 08: North America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country, 2022-2031
Table 09: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product, 2022-2031
Table 10: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
Table 11: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
Table 12: Europe Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 13: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product
Table 14: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method
Table 15: Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user
Table 16 Asia Pacific Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region
Table 17: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product
Table 18: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
Table 19: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
Table 20: Latin America Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2031
Table 21: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Product, 2022-2031
Table 22: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Method, 2022-2031
Table 23: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by End-user, 2022-2031
Table 24: Middle East & Africa Point-of-Care Coagulation Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022-2031